Syria vs Trinidad and Tobago: Estimated antiretroviral therapy coverage among people living with HIV
Syria
65.0%
in 2025
Trinidad and Tobago
66.0%
in 2025
Syria rank
98th
Trinidad and Tobago rank
95th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Syria
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 66.0% against 65.0% in Syria, a difference of 1.0%.
Across all 26 years both countries report, Trinidad and Tobago has been ahead every year.
Syria ranks 98th and Trinidad and Tobago ranks 95th of 143 countries.
Trinidad and Tobago has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Syria | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.5% | 12.2% | 8.7% | Trinidad and Tobago |
| 2010s | 24.3% | 54.9% | 30.6% | Trinidad and Tobago |
| 2020s | 49.8% | 64.0% | 14.2% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Syria or Trinidad and Tobago?
- Trinidad and Tobago, at 66.0% against 65.0% in Syria as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Syria and Trinidad and Tobago?
- 1.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Syria and Trinidad and Tobago?
- 26 years are reported by both, from 2000 to 2025.
- How do Syria and Trinidad and Tobago rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Syria ranks 98th and Trinidad and Tobago ranks 95th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.